Abstract
Antiretroviral treatment has undergone major changes in the last 20 years, from monotherapy, to dual therapy and finally to triple therapy. Lately, more focus has been placed on better, more well-tolerated combinations and formulations. As in most other disciplines in medicine, the development of paediatric HIV dosages and formulations always tends to lag behind adult research. Twenty years ago, it could take several years before data were available to enable the use of life-saving antiretrovirals in children. Paediatricians, being ever resourceful, were not prepared to let their paediatric patients suffer despite the lack of data or formulations and so made a plan. This article describes some of the trials and tribulations that we went through trying to make sure that our paediatric HIV patients not only survived but thrived. Clinicians treating paediatric patients today have it so much easier because of what our colleagues and their patients went through in those early days.
Highlights
Read online: Scan this QR code with your smart phone or mobile device to read online
This article describes some of the trials and tribulations that we went through trying to make sure that our paediatric HIV patients survived but thrived
It is hard to convey the sense of helplessness felt by those of us who worked in the pre-antiretroviral treatment (ART) era when faced with a sick HIV-infected child and mother
Summary
Read online: Scan this QR code with your smart phone or mobile device to read online. Looking back at paediatric HIV treatment in South Africa.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have